Novo Nordisk A/S, the largest industry player, is investing in new diabetes drugs that can be given as a pill rather than being injected in a bid to survive pricing …
Novo Nordisk A/S, the largest industry player, is investing in new diabetes drugs that can be given as a pill rather than being injected in a bid to survive pricing …